News & Media :: Vedanta Biosciences, Inc.

Jul 1, 2019

Vedanta Biosciences Announces First Patient Enrolled in VE416 Phase 1b/2 Food Allergy Clinical Study

Recent News

Jun 25, 2019

Vedanta Biosciences’ Silvia Caballero, Ph.D., Named as an MIT Technology Review Global Innovator Under 35

May 23, 2019

Microbiome therapies could be the next frontier in medicine. But how exactly do you make them?

May 13, 2019

Vedanta Biosciences Closes Extended $45.5 Million Series C Financing

May 7, 2019

Vedanta Biosciences Key Microbiome Patent Upheld in European Opposition Proceedings

View All News View All Press Releases